scispace - formally typeset
C

Christopher P. Jenkinson

Researcher at University of Texas at Austin

Publications -  91
Citations -  8142

Christopher P. Jenkinson is an academic researcher from University of Texas at Austin. The author has contributed to research in topics: Insulin resistance & Insulin. The author has an hindex of 40, co-authored 91 publications receiving 7484 citations. Previous affiliations of Christopher P. Jenkinson include The University of Texas Rio Grande Valley & Texas Biomedical Research Institute.

Papers
More filters
Journal ArticleDOI

The genetic architecture of type 2 diabetes

Christian Fuchsberger, +349 more
- 11 Jul 2016 - 
TL;DR: In this paper, the authors performed whole-genome sequencing in 2,657 European individuals with and without diabetes, and exome sequencing for 12,940 individuals from five ancestry groups.

The genetic architecture of type 2 diabetes

Christian Fuchsberger, +300 more
TL;DR: Large-scale sequencing does not support the idea that lower-frequency variants have a major role in predisposition to type 2 diabetes, but most fell within regions previously identified by genome-wide association studies.
Journal ArticleDOI

Comparative properties of arginases.

TL;DR: An outline of the current state of arginase research is presented by giving a comparative overview ofArginases and their associated properties by way of comparison with previous work.
Journal ArticleDOI

Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study.

TL;DR: Differences in insulin sensitivity and insulin action in subjects with impaired fasting glucose and impaired glucose tolerance may predict different rates of progression to type 2 diabetes and varying susceptibility to cardiovascular disease.
Journal ArticleDOI

Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico

A. L. Williams Amy, +128 more
- 06 Feb 2014 - 
TL;DR: Analysis in Mexican and Latin American individuals identified SLC16A11 as a novel candidate gene for type 2 diabetes with a possible role in triacylglycerol metabolism and an archaic genome sequence indicated that the risk haplotype introgressed into modern humans via admixture with Neanderthals.